We conducted the Apixaban Cancer Associated Thrombosis ... For the primary outcome and the key secondary outcome, the treatment effect was estimated as the subhazard ratio, with adjustment ...

CHICAGO — Extended therapy with reduced-dose apixaban is just as effective as ... in this trial population, the effect of bleeding on overall quality of life is particularly important and ...

Extended treatment with low-dose apixaban was noninferior to a full ... in which more than 80% of the patients had an incurable disease, the effect of bleeding on overall quality of life will ...

This means apixaban cut the clot risk by nearly half. It also improved the chances of keeping the vascular access working without further issues (32% failure rate versus 50% in the control group).

CHICAGO, IL—For patients with active cancer who’ve had venous thromboembolism (VTE), 12-month extended anticoagulation with reduced-dose apixaban is noninferior ... patients had an incurable disease, ...